US Map / Rhode Island
State RI

Clinical Trials in Rhode Island

Rhode Island is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Rhode Island and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 65 actively recruiting studies with Rhode Island sites out of 65 registered in total. The busiest research areas in Rhode Island are Ulcerative Colitis, Diabetic Peripheral Neuropathic Pain, Pulmonary Hypertension. Leading sponsors running trials in the state include Brown University, National Cancer Institute (NCI), Pfizer. By stage, Rhode Island trials break down as Phase 1 (5), Phase 2 (11), Phase 3 (19), Phase 4 (1).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
65
Recruiting Now
65
← Back to US Map
Top Conditions in Rhode Island
Ulcerative Colitis (3)Diabetic Peripheral Neuropathic Pain (2)Pulmonary Hypertension (2)COVID-19 (2)Obesity (2)Solid Tumor (2)Ovarian Cancer (2)Healthy (1)Pareses (1)Lower Extremity (1)Multiple Myeloma (1)Pelvic Organ Prolapse (1)

Frequently Asked Questions — Clinical Trials in Rhode Island

How many clinical trials are currently recruiting in Rhode Island?
ClinicalMetric currently tracks 65 actively recruiting clinical trials with at least one location in Rhode Island. The total number of registered studies—including active but not currently enrolling trials—is 65. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Rhode Island?
Rhode Island hosts clinical trials across a broad range of medical conditions, including Ulcerative Colitis, Diabetic Peripheral Neuropathic Pain, Pulmonary Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Rhode Island serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Rhode Island?
To join a clinical trial in Rhode Island, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Rhode Island maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Rhode Island

NCT06409975 N/A
Recruiting
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and N...
Condition
Healthy
Enrollment
50 pts
Location
United States
Sponsor
University of Rhode Island
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT05552222 Phase 3
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Condition
Multiple Myeloma
Enrollment
1,590 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
View Trial →
NCT07231419 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With ...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
734 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07218016 N/A
Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
Condition
Pelvic Organ Prolapse
Enrollment
288 pts
Location
United States
Sponsor
NICHD Pelvic Floor Disorders N
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05861531 N/A
Recruiting
Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
Condition
Language Delay
Enrollment
124 pts
Location
United States
Sponsor
Women and Infants Hospital of
View Trial →
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
473 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
View Trial →
NCT06370520 N/A
Recruiting
Screening Emotions in Adolescents at the Hospital for mTBI
Condition
Brain Injury Traumatic Mild
Enrollment
2,592 pts
Location
United States
Sponsor
University of California, Davi
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT05145478 N/A
Recruiting
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotri...
Condition
Femoral Arterial Calcification
Enrollment
50 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07132788 N/A
Recruiting
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Condition
Pulmonary Hypertension
Enrollment
150 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT02735707 Phase 3
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acqu...
Condition
Respiratory Tract Diseases
Enrollment
20,000 pts
Location
United States, Australia, Belgium
Sponsor
UMC Utrecht
View Trial →
NCT07339423 Phase 3
Recruiting
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...
Condition
Obesity
Enrollment
1,150 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT07197476 N/A
Recruiting
Adolescent Stress and Substance Intervention Subsequent to Trauma
Condition
PTSD
Enrollment
92 pts
Location
United States
Sponsor
Rhode Island Hospital
View Trial →
NCT07316543 N/A
Recruiting
Cognitive Rehabilitation for Veterans With PNES
Condition
Psychogenic Nonepileptic Seizures (PNES)
Enrollment
47 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07683325 Phase 2
Recruiting
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Com...
Condition
Fibrostenotic Crohn's Disease
Enrollment
320 pts
Location
United States, Serbia, United Kingdom
Sponsor
Agomab Spain S.L.U.
View Trial →
NCT07287150 Phase 2
Recruiting
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
100 pts
Location
United States, Australia, Brazil
Sponsor
Hoffmann-La Roche
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT07594743 N/A
Recruiting
Feasibility and Acceptability of a Novel Digital Intervention to Prevent Paterna...
Condition
Paternal Postpartum Depression
Enrollment
90 pts
Location
United States
Sponsor
Women and Infants Hospital of
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Enrollment
200 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
Page 1 of 3 — 65 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology